Potential role of mammalian target of rapamycin inhibitors in breast cancer therapy

Clin Breast Cancer. 2005 Oct;6(4):357-60. doi: 10.3816/CBC.2005.n.041.
No abstract available

Publication types

  • Research Support, N.I.H., Extramural
  • Review

MeSH terms

  • Animals
  • Antineoplastic Combined Chemotherapy Protocols / therapeutic use*
  • Breast Neoplasms / drug therapy*
  • Breast Neoplasms / metabolism
  • Female
  • Genetic Markers
  • Humans
  • Intracellular Signaling Peptides and Proteins / pharmacology
  • Patient Selection
  • Protein Kinases / drug effects
  • Protein Kinases / metabolism
  • Sirolimus / analogs & derivatives
  • Sirolimus / antagonists & inhibitors
  • Sirolimus / therapeutic use*
  • TOR Serine-Threonine Kinases

Substances

  • Genetic Markers
  • Intracellular Signaling Peptides and Proteins
  • protein kinase modulator
  • temsirolimus
  • Protein Kinases
  • MTOR protein, human
  • TOR Serine-Threonine Kinases
  • Sirolimus